Monday, March 27, 2023 | Back issues
Courthouse News Service Courthouse News Service

$2.6 Billion Drug Merger

WILMINGTON, Del. - Directors are selling Santarus too cheaply through an unfair process to Salix Pharmaceuticals, for $32 a share or $2.6 billion, shareholders claim in a class action in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.